882 related articles for article (PubMed ID: 14529278)
1. Humoral immune response to fibrillar beta-amyloid peptide.
Miller DL; Currie JR; Mehta PD; Potempska A; Hwang YW; Wegiel J
Biochemistry; 2003 Oct; 42(40):11682-92. PubMed ID: 14529278
[TBL] [Abstract][Full Text] [Related]
2. Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers.
Robert R; Dolezal O; Waddington L; Hattarki MK; Cappai R; Masters CL; Hudson PJ; Wark KL
Protein Eng Des Sel; 2009 Mar; 22(3):199-208. PubMed ID: 18927231
[TBL] [Abstract][Full Text] [Related]
3. Epitope and isotype specificities of antibodies to beta -amyloid peptide for protection against Alzheimer's disease-like neuropathology.
Bard F; Barbour R; Cannon C; Carretto R; Fox M; Games D; Guido T; Hoenow K; Hu K; Johnson-Wood K; Khan K; Kholodenko D; Lee C; Lee M; Motter R; Nguyen M; Reed A; Schenk D; Tang P; Vasquez N; Seubert P; Yednock T
Proc Natl Acad Sci U S A; 2003 Feb; 100(4):2023-8. PubMed ID: 12566568
[TBL] [Abstract][Full Text] [Related]
4. Human monoclonal antibodies against amyloid-beta from healthy adults.
Geylis V; Kourilov V; Meiner Z; Nennesmo I; Bogdanovic N; Steinitz M
Neurobiol Aging; 2005 May; 26(5):597-606. PubMed ID: 15708434
[TBL] [Abstract][Full Text] [Related]
5. Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers.
Meli G; Visintin M; Cannistraci I; Cattaneo A
J Mol Biol; 2009 Apr; 387(3):584-606. PubMed ID: 19361429
[TBL] [Abstract][Full Text] [Related]
6. Abeta42 immunization in Alzheimer's disease generates Abeta N-terminal antibodies.
Lee M; Bard F; Johnson-Wood K; Lee C; Hu K; Griffith SG; Black RS; Schenk D; Seubert P
Ann Neurol; 2005 Sep; 58(3):430-5. PubMed ID: 16130106
[TBL] [Abstract][Full Text] [Related]
7. Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease.
Barghorn S; Nimmrich V; Striebinger A; Krantz C; Keller P; Janson B; Bahr M; Schmidt M; Bitner RS; Harlan J; Barlow E; Ebert U; Hillen H
J Neurochem; 2005 Nov; 95(3):834-47. PubMed ID: 16135089
[TBL] [Abstract][Full Text] [Related]
8. Humoral immune responses to peptides derived from the beta-amyloid peptide C-terminal sequence.
Miller DL; Potempska A; Mehta PD
Amyloid; 2007 Mar; 14(1):39-50. PubMed ID: 17453624
[TBL] [Abstract][Full Text] [Related]
9. Single-domain antibodies recognize selectively small oligomeric forms of amyloid beta, prevent Abeta-induced neurotoxicity and inhibit fibril formation.
Lafaye P; Achour I; England P; Duyckaerts C; Rougeon F
Mol Immunol; 2009 Feb; 46(4):695-704. PubMed ID: 18930548
[TBL] [Abstract][Full Text] [Related]
10. An intersheet packing interaction in A beta fibrils mapped by disulfide cross-linking.
Shivaprasad S; Wetzel R
Biochemistry; 2004 Dec; 43(49):15310-7. PubMed ID: 15581343
[TBL] [Abstract][Full Text] [Related]
11. Immunogenic, antigenic, fibrillogenic and inflammatory properties of new simplified beta-amyloid peptides.
Rossi M; Piovesan P; Ghirardi O; Mastroianni D; Bombardi V; Battistini L; Cencioni MT; Capobianco D; Borsini F; Colombo M; Verdoliva A
Mol Immunol; 2009 Aug; 46(13):2524-32. PubMed ID: 19535144
[TBL] [Abstract][Full Text] [Related]
12. Dendrimeric Abeta1-15 is an effective immunogen in wildtype and APP-tg mice.
Seabrook TJ; Thomas K; Jiang L; Bloom J; Spooner E; Maier M; Bitan G; Lemere CA
Neurobiol Aging; 2007 Jun; 28(6):813-23. PubMed ID: 16725229
[TBL] [Abstract][Full Text] [Related]
13. An amyloid-beta protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer's disease.
Lord A; Gumucio A; Englund H; Sehlin D; Sundquist VS; Söderberg L; Möller C; Gellerfors P; Lannfelt L; Pettersson FE; Nilsson LN
Neurobiol Dis; 2009 Dec; 36(3):425-34. PubMed ID: 19703562
[TBL] [Abstract][Full Text] [Related]
14. Specific recognition of the C-terminal end of A beta 42 by a high affinity monoclonal antibody.
Axelsen TV; Holm A; Birkelund S; Christiansen G; Ploug M; Holm IE
Mol Immunol; 2009 Jul; 46(11-12):2267-73. PubMed ID: 19447496
[TBL] [Abstract][Full Text] [Related]
15. Autoimmunity in Alzheimer's disease: increased levels of circulating IgGs binding Abeta and RAGE peptides.
Mruthinti S; Buccafusco JJ; Hill WD; Waller JL; Jackson TW; Zamrini EY; Schade RF
Neurobiol Aging; 2004 Sep; 25(8):1023-32. PubMed ID: 15212827
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
[TBL] [Abstract][Full Text] [Related]
17. Acetylcholinesterase promotes the aggregation of amyloid-beta-peptide fragments by forming a complex with the growing fibrils.
Alvarez A; Opazo C; Alarcón R; Garrido J; Inestrosa NC
J Mol Biol; 1997 Sep; 272(3):348-61. PubMed ID: 9325095
[TBL] [Abstract][Full Text] [Related]
18. Degradation of beta-amyloid by proteolytic antibody light chains.
Rangan SK; Liu R; Brune D; Planque S; Paul S; Sierks MR
Biochemistry; 2003 Dec; 42(48):14328-34. PubMed ID: 14640701
[TBL] [Abstract][Full Text] [Related]
19. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
Güntert A; Döbeli H; Bohrmann B
Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
[TBL] [Abstract][Full Text] [Related]
20. Selection and characterization of Affibody ligands binding to Alzheimer amyloid beta peptides.
Grönwall C; Jonsson A; Lindström S; Gunneriusson E; Ståhl S; Herne N
J Biotechnol; 2007 Jan; 128(1):162-83. PubMed ID: 17088007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]